Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Scinai Immunotherapeutics Ltd. (SCNI)

2.7700
-0.1200
(-4.17%)
As of 10:21:48 AM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for SCNI

Recent News: SCNI

View More
Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases

Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases
PR Newswire yesterday
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
PR Newswire last month
Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025

Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025
PR Newswire last month
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
PR Newswire last month
Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences
PR Newswire 3 months ago
Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.
PR Newswire 4 months ago
Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board
PR Newswire 4 months ago
There Are Some Reasons To Suggest That Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Are A Poor Reflection Of Profitability

There Are Some Reasons To Suggest That Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Are A Poor Reflection Of Profitability
Simply Wall St. 4 months ago
Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board
PR Newswire 5 months ago
Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million
PR Newswire 5 months ago
Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024
PR Newswire 5 months ago
View More

Related Tickers

HTD.MU Corcept Therapeutics Inc
63.62
0.00%
 
25I.SG ImmuPharma PLC
0.0325
-1.52%
 
HQ1.MU Oruka Therapeutics Inc. R
9.10
0.00%
 
22Z.SG Zealand Pharma A/S
62.04
+0.81%
 
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
 
PI3.DU Gubra AS
54.00
+9.27%
 
T3X.BE Telix Pharmaceuticals Ltd
16.55
+8.21%
 
AYJ.HA Valneva SE
2.8720
-0.69%
 
22UA.MU BioNTech SE
91.15
-0.16%
 
BNTX.VI BioNTech SE
92.10
+1.10%
 
Waiting for permission
Allow microphone access to enable voice search

Try again.